Free Access
| Issue |
J Extra Corpor Technol
Volume 38, Number 4, December 2006
|
|
|---|---|---|
| Page(s) | 307 - 309 | |
| DOI | https://doi.org/10.1051/ject/200638307 | |
| Published online | 15 December 2006 | |
- Zucker ML, Jobes C, Siegal M, et al. Activated clotting time (ACT) testing: analysis of reproducibility. J Extra Corpor Technol. 1999;31:130–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bull BS, Korpman RA, Huse WM, et al. Heparin therapy during extracorporeal circulation: I Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg. 1975;69:674–82. [CrossRef] [Google Scholar]
- Young JA, Kisker CT, Doty DB. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and appearance of fibrin monomer. Ann Thorac Surg. 1978;26:231–40. [CrossRef] [Google Scholar]
- Dietrich W, Spannagl M, Schramm W, et al. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;102:505–14. [CrossRef] [Google Scholar]
- Habbab MA, Haft JI. Heparin resistance induced by intravenous nitroglycerin. A word of caution when both drugs are used concomitantly. Arch Intern Med. 1987;147:857–60. [CrossRef] [PubMed] [Google Scholar]
- Esposito RA, Culliford AT, Colvin SB, et al. Heparin resistance during cardiopulmonary bypass: the role of heparin pretreatment. J Thorac Cardiovasc Surg. 1983;85:346–53. [CrossRef] [Google Scholar]
- Lemmer JH, Despotis GJ. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2002;123:213–7. [CrossRef] [Google Scholar]
- Dumond M, Dumond D, Cook C, et al. A clinical evaluation of the correlation and reproducibility of three automated devices for measurement of activated clotting times. J Extra Corpor Technol. 1990;22:30–4. [CrossRef] [EDP Sciences] [Google Scholar]
- Clark TD, Ecklund JM, McCall MM, Wolk DR, Riley JB. Comparison of three methods to estimate heparin loading dose for cardiopulmonary bypass. J Extra Corpor Technol. 1996;28:67–70. [Google Scholar]
- Hardy J, Belisle S, Robitaille D, Perrault J, Roy M, Gagnon L. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromagenic substrate for activated factor X. J Thorac Cardiovasc Surg. 1996;112:154–61. [CrossRef] [Google Scholar]
- Avidan MS, Levy JH, Scholz J, et al. A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass. Anesthesiology. 2005;102:276–84. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.